{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T04:55:22Z","timestamp":1793422522202,"version":"4.5.0"},"reference-count":49,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2019,12,31]],"date-time":"2019-12-31T00:00:00Z","timestamp":1577750400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0226854","type":"journal-article","created":{"date-parts":[[2019,12,31]],"date-time":"2019-12-31T13:26:26Z","timestamp":1577798786000},"page":"e0226854","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":56,"title":["Thrombospondin-I is a critical modulator in non-alcoholic steatohepatitis (NASH)"],"prefix":"10.1371","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1554-8365","authenticated-orcid":true,"given":"Jessica","family":"Min-DeBartolo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franklin","family":"Schlerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep","family":"Akare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"McMahon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutian","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jameel","family":"Syed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4735-4212","authenticated-orcid":true,"given":"Baohong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert V.","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2019,12,31]]},"reference":[{"issue":"9963","key":"pone.0226854.ref001","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0140-6736(14)61682-2","article-title":"Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990\u20132013: a systematic analysis for the Global Burden of Disease Study 2013","volume":"385","author":"GBD Mortality","year":"2015","journal-title":"Lancet"},{"issue":"3","key":"pone.0226854.ref002","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/nri3623","article-title":"Liver fibrosis and repair: immune regulation of wound healing in a solid organ","volume":"14","author":"A Pellicoro","year":"2014","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"pone.0226854.ref003","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.jhep.2011.09.024","article-title":"Clinical evidence for the regression of liver fibrosis","volume":"56","author":"EL Ellis","year":"2012","journal-title":"J Hepatol"},{"issue":"1","key":"pone.0226854.ref004","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1053\/j.gastro.2010.09.038","article-title":"Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study","volume":"140","author":"CD Williams","year":"2011","journal-title":"Gastroenterology"},{"issue":"22","key":"pone.0226854.ref005","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1001\/jama.2015.5370","article-title":"Nonalcoholic fatty liver disease: a systematic review","volume":"313","author":"ME Rinella","year":"2015","journal-title":"JAMA"},{"issue":"11","key":"pone.0226854.ref006","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1002\/lt.24223","article-title":"De novo hepatic steatosis drives atherogenic risk in liver transplantation recipients","volume":"21","author":"MO Idowu","year":"2015","journal-title":"Liver Transpl"},{"issue":"6","key":"pone.0226854.ref007","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1002\/hep.28504","article-title":"Nonalcoholic fatty liver disease and elastography: Incremental advances but work still to be done","volume":"63","author":"WN Hannah","year":"2016","journal-title":"Hepatology"},{"issue":"1","key":"pone.0226854.ref008","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/hep.26053","article-title":"A novel murine model to deplete hepatic stellate cells uncovers their role in amplifying liver damage in mice","volume":"57","author":"JE Puche","year":"2013","journal-title":"Hepatology"},{"key":"pone.0226854.ref009","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.matbio.2014.01.012","article-title":"Current understanding of the thrombospondin-1 interactome","volume":"37","author":"A Resovi","year":"2014","journal-title":"Matrix Biol"},{"issue":"19","key":"pone.0226854.ref010","doi-asserted-by":"crossref","first-page":"13586","DOI":"10.1074\/jbc.274.19.13586","article-title":"The activation sequence of thrombospondin-1 interacts with the latency-associated peptide to regulate activation of latent transforming growth factor-beta","volume":"274","author":"SM Ribeiro","year":"1999","journal-title":"J Biol Chem"},{"issue":"13","key":"pone.0226854.ref011","doi-asserted-by":"crossref","first-page":"7304","DOI":"10.1074\/jbc.270.13.7304","article-title":"Regulation of transforming growth factor-beta activation by discrete sequences of thrombospondin 1","volume":"270","author":"S Schultz-Cherry","year":"1995","journal-title":"J Biol Chem"},{"issue":"7","key":"pone.0226854.ref012","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/S0092-8674(00)81460-9","article-title":"Thrombospondin-1 is a major activator of TGF-beta1 in vivo","volume":"93","author":"SE Crawford","year":"1998","journal-title":"Cell"},{"issue":"532","key":"pone.0226854.ref013","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aar2566","article-title":"Thrombospondin-1 promotes matrix homeostasis by interacting with collagen and lysyl oxidase precursors and collagen cross-linking sites","volume":"11","author":"S Rosini","year":"2018","journal-title":"Sci Signal"},{"issue":"5","key":"pone.0226854.ref014","doi-asserted-by":"crossref","first-page":"G364","DOI":"10.1152\/ajpgi.00077.2013","article-title":"Genome-wide transcriptome analysis identifies novel gene signatures implicated in human chronic liver disease","volume":"305","author":"RL Smalling","year":"2013","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"4","key":"pone.0226854.ref015","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1097\/00005176-199904000-00008","article-title":"Increased expression of transforming growth factor-beta1 and thrombospondin-1 in congenital hepatic fibrosis: possible role of the hepatic stellate cell","volume":"28","author":"M El-Youssef","year":"1999","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"5","key":"pone.0226854.ref016","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/S0168-8278(03)00377-5","article-title":"A blocking peptide for transforming growth factor-beta1 activation prevents hepatic fibrosis in vivo","volume":"39","author":"H Kondou","year":"2003","journal-title":"J Hepatol"},{"issue":"4","key":"pone.0226854.ref017","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.3892\/etm.2016.3640","article-title":"LSKL peptide alleviates subarachnoid fibrosis and hydrocephalus by inhibiting TSP1-mediated TGF-beta1 signaling activity following subarachnoid hemorrhage in rats","volume":"12","author":"F Liao","year":"2016","journal-title":"Exp Ther Med"},{"issue":"12","key":"pone.0226854.ref018","doi-asserted-by":"crossref","first-page":"4548","DOI":"10.1210\/en.2013-1587","article-title":"Thrombospondin 1 mediates high-fat diet-induced muscle fibrosis and insulin resistance in male mice","volume":"154","author":"M Inoue","year":"2013","journal-title":"Endocrinology"},{"issue":"6","key":"pone.0226854.ref019","doi-asserted-by":"crossref","first-page":"F871","DOI":"10.1152\/ajprenal.00209.2013","article-title":"Thrombospondin 1 mediates renal dysfunction in a mouse model of high-fat diet-induced obesity","volume":"305","author":"W Cui","year":"2013","journal-title":"Am J Physiol Renal Physiol"},{"issue":"7","key":"pone.0226854.ref020","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1002\/bjs.9765","article-title":"Effect of LSKL peptide on thrombospondin 1-mediated transforming growth factor beta signal activation and liver regeneration after hepatectomy in an experimental model","volume":"102","author":"H Kuroki","year":"2015","journal-title":"Br J Surg"},{"issue":"10","key":"pone.0226854.ref021","doi-asserted-by":"crossref","first-page":"4545","DOI":"10.1210\/en.2005-0532","article-title":"Modulation of angiogenesis during adipose tissue development in murine models of obesity","volume":"146","author":"G Voros","year":"2005","journal-title":"Endocrinology"},{"issue":"2","key":"pone.0226854.ref022","doi-asserted-by":"crossref","first-page":"432","DOI":"10.2337\/db07-0840","article-title":"Thrombospondin-1 is an adipokine associated with obesity, adipose inflammation, and insulin resistance","volume":"57","author":"V Varma","year":"2008","journal-title":"Diabetes"},{"issue":"3","key":"pone.0226854.ref023","doi-asserted-by":"crossref","first-page":"E439","DOI":"10.1152\/ajpendo.00006.2013","article-title":"Thrombospondin-1 regulates adiposity and metabolic dysfunction in diet-induced obesity enhancing adipose inflammation and stimulating adipocyte proliferation","volume":"305","author":"P Kong","year":"2013","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"3","key":"pone.0226854.ref024","doi-asserted-by":"crossref","first-page":"777","DOI":"10.2353\/ajpath.2007.070056","article-title":"A thrombospondin-1 antagonist of transforming growth factor-beta activation blocks cardiomyopathy in rats with diabetes and elevated angiotensin II","volume":"171","author":"S Belmadani","year":"2007","journal-title":"Am J Pathol"},{"issue":"6","key":"pone.0226854.ref025","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1016\/j.ajpath.2011.02.039","article-title":"Blockade of TSP1-dependent TGF-beta activity reduces renal injury and proteinuria in a murine model of diabetic nephropathy","volume":"178","author":"A Lu","year":"2011","journal-title":"Am J Pathol"},{"issue":"24","key":"pone.0226854.ref026","doi-asserted-by":"crossref","first-page":"18528","DOI":"10.1074\/jbc.M109.099333","article-title":"Specific contribution of methionine and choline in nutritional nonalcoholic steatohepatitis: impact on mitochondrial S-adenosyl-L-methionine and glutathione","volume":"285","author":"F Caballero","year":"2010","journal-title":"J Biol Chem"},{"key":"pone.0226854.ref027","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12864-015-2356-9","article-title":"QuickRNASeq lifts large-scale RNA-seq data analyses to the next level of automation and interactive visualization","volume":"17","author":"S Zhao","year":"2016","journal-title":"BMC Genomics"},{"issue":"7","key":"pone.0226854.ref028","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"ME Ritchie","year":"2015","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"pone.0226854.ref029","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/iep.12008","article-title":"An improved mouse model that rapidly develops fibrosis in non-alcoholic steatohepatitis","volume":"94","author":"M Matsumoto","year":"2013","journal-title":"Int J Exp Pathol"},{"issue":"7","key":"pone.0226854.ref030","doi-asserted-by":"crossref","first-page":"e6447","DOI":"10.1371\/journal.pone.0006447","article-title":"Mining biological pathways using WikiPathways web services","volume":"4","author":"T Kelder","year":"2009","journal-title":"PLoS One"},{"key":"pone.0226854.ref031","unstructured":"WikiPathways 2018. wikipathways.org."},{"issue":"9","key":"pone.0226854.ref032","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1136\/gut.2010.216077","article-title":"Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease","volume":"59","author":"S McPherson","year":"2010","journal-title":"Gut"},{"issue":"5","key":"pone.0226854.ref033","doi-asserted-by":"crossref","first-page":"e0127991","DOI":"10.1371\/journal.pone.0127991","article-title":"Mouse models of diet-induced nonalcoholic steatohepatitis reproduce the heterogeneity of the human disease","volume":"10","author":"MV Machado","year":"2015","journal-title":"PLoS One"},{"issue":"4","key":"pone.0226854.ref034","doi-asserted-by":"crossref","first-page":"E311","DOI":"10.1152\/ajpendo.00161.2015","article-title":"Cross-talk between branched-chain amino acids and hepatic mitochondria is compromised in nonalcoholic fatty liver disease","volume":"309","author":"NE Sunny","year":"2015","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"12","key":"pone.0226854.ref035","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/nrendo.2014.171","article-title":"Branched-chain amino acids in metabolic signalling and insulin resistance","volume":"10","author":"CJ Lynch","year":"2014","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"pone.0226854.ref036","doi-asserted-by":"crossref","first-page":"14485","DOI":"10.1038\/s41598-017-14974-w","article-title":"Plasma amino acid profile associated with fatty liver disease and co-occurrence of metabolic risk factors","volume":"7","author":"M Yamakado","year":"2017","journal-title":"Sci Rep"},{"issue":"10","key":"pone.0226854.ref037","doi-asserted-by":"crossref","first-page":"e0138889","DOI":"10.1371\/journal.pone.0138889","article-title":"Adipose Tissue Dysfunction and Altered Systemic Amino Acid Metabolism Are Associated with Non-Alcoholic Fatty Liver Disease","volume":"10","author":"S Cheng","year":"2015","journal-title":"PLoS One"},{"issue":"5","key":"pone.0226854.ref038","doi-asserted-by":"crossref","first-page":"e230","DOI":"10.1038\/oncsis.2016.37","article-title":"Dietary fat overcomes the protective activity of thrombospondin-1 signaling in the Apc(Min\/+) model of colon cancer","volume":"5","author":"DR Soto-Pantoja","year":"2016","journal-title":"Oncogenesis"},{"issue":"3","key":"pone.0226854.ref039","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1258\/002367702320162414","article-title":"Advantages of glutamate dehydrogenase as a blood biomarker of acute hepatic injury in rats","volume":"36","author":"PJ O\u2019Brien","year":"2002","journal-title":"Lab Anim"},{"issue":"4","key":"pone.0226854.ref040","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1172\/JCI59755","article-title":"The mechanism underlying acetaminophen-induced hepatotoxicity in humans and mice involves mitochondrial damage and nuclear DNA fragmentation","volume":"122","author":"MR McGill","year":"2012","journal-title":"J Clin Invest"},{"issue":"1","key":"pone.0226854.ref041","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1093\/toxsci\/kft087","article-title":"Serum glutamate dehydrogenase\u2014biomarker for liver cell death or mitochondrial dysfunction?","volume":"134","author":"H Jaeschke","year":"2013","journal-title":"Toxicol Sci"},{"issue":"6","key":"pone.0226854.ref042","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1002\/hep.26461","article-title":"Hepatoprotective effects of the dual peroxisome proliferator-activated receptor alpha\/delta agonist, GFT505, in rodent models of nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis","volume":"58","author":"B Staels","year":"2013","journal-title":"Hepatology"},{"issue":"3","key":"pone.0226854.ref043","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.dld.2007.10.002","article-title":"A pilot trial of fenofibrate for the treatment of non-alcoholic fatty liver disease","volume":"40","author":"C Fernandez-Miranda","year":"2008","journal-title":"Dig Liver Dis"},{"issue":"2","key":"pone.0226854.ref044","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/S0168-8278(99)80243-8","article-title":"A controlled trial of gemfibrozil in the treatment of patients with nonalcoholic steatohepatitis","volume":"31","author":"M Basaranoglu","year":"1999","journal-title":"J Hepatol"},{"issue":"6","key":"pone.0226854.ref045","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1002\/hep.510230624","article-title":"Ursodeoxycholic acid or clofibrate in the treatment of non-alcohol-induced steatohepatitis: a pilot study","volume":"23","author":"J Laurin","year":"1996","journal-title":"Hepatology"},{"issue":"22","key":"pone.0226854.ref046","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1056\/NEJMoa060326","article-title":"A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis","volume":"355","author":"R Belfort","year":"2006","journal-title":"N Engl J Med"},{"issue":"4","key":"pone.0226854.ref047","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.cgh.2017.12.001","article-title":"Response to Pioglitazone in Patients With Nonalcoholic Steatohepatitis With vs Without Type 2 Diabetes","volume":"16","author":"F Bril","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"12","key":"pone.0226854.ref048","doi-asserted-by":"crossref","first-page":"4447","DOI":"10.1172\/JCI82204","article-title":"Mitochondrial metabolism mediates oxidative stress and inflammation in fatty liver","volume":"125","author":"S Satapati","year":"2015","journal-title":"J Clin Invest"},{"issue":"6227","key":"pone.0226854.ref049","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1126\/science.aaa0672","article-title":"Controlled-release mitochondrial protonophore reverses diabetes and steatohepatitis in rats","volume":"347","author":"RJ Perry","year":"2015","journal-title":"Science"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0226854","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,31]],"date-time":"2019-12-31T13:26:54Z","timestamp":1577798814000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0226854"}},"subtitle":[],"editor":[{"given":"G. William","family":"Wong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,12,31]]},"references-count":49,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2019,12,31]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0226854","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,31]]}}}